Fidelity International’s BioNTech BNTX Stock Holding History

Fidelity International’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.52K	Hold	46	–	–	﹤0.01%	1130
2026 Q2	$4.28K	Hold	46	–	–	﹤0.01%	1139
2026 Q1	$4.09K	Buy	+46	New	+$4.73K	﹤0.01%	1099

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

GSK plc London $497M AUM 35.1% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

LBP AM Paris, France $11.2B AUM 34.48% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity International's BNTX Position: Q3 2026 in Review

Fidelity International held its BioNTech (BNTX) position steady in Q3 2026 at 46 shares worth $4.52K. The position accounts for ﹤0.01% of the portfolio, ranked #1130.

Fidelity International first reported a position in BNTX in Q1 2026 and has held it in 3 quarters since. 144 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

Fidelity International held 46 shares of BioNTech worth $4.52K as of Q3 2026.
Fidelity International left its BioNTech share count unchanged in Q3 2026.
BioNTech made up ﹤0.01% of Fidelity International's portfolio in Q3 2026, its #1130 holding.
Fidelity International first reported a position in BioNTech in Q1 2026 and has held it in 3 quarters since.
144 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Fidelity International's 13F filing for Q3 2026, filed 10 Nov 2026.